We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
-1.51%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$393M
AUM Growth
+$25.3M
Cap. Flow
+$32.9M
Cap. Flow %
8.36%
Top 10 Hldgs %
80.79%
Holding
223
New
14
Increased
85
Reduced
52
Closed
29

Top Buys

Rank Stock Value
1
MBB icon
iShares MBS ETF
MBB
+$10.8M
2
VMBS icon
Vanguard Mortgage-Backed Securities ETF
VMBS
+$10.2M
3
MCRB icon
Seres Therapeutics
MCRB
+$1.62M
4
VUZI icon
Vuzix
VUZI
+$1.34M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$1.16M

Top Sells

Rank Stock Value
1
OUST icon
Ouster
OUST
+$1.06M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.02M
3
TVTX icon
Travere Therapeutics
TVTX
+$897K
4
ADCT icon
ADC Therapeutics
ADCT
+$633K
5
RBOT
Vicarious Surgical
RBOT
+$548K

Sector Composition

Rank Sector Weight
1 Real Estate 18.05%
2 Healthcare 12.08%
3 Technology 1.59%
4 Financials 1.03%
5 Industrials 0.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JCI icon
176
Johnson Controls International
JCI
$85B
$82K 0.02%
1,203
+2
+0.2% +$144
AJG icon
177
Arthur J. Gallagher & Co
AJG
$65.2B
$81K 0.02%
548
– –
RVTY icon
178
Revvity
RVTY
$11.9B
$81K 0.02%
469
-1
-0.2% -$176
DHR icon
179
Danaher
DHR
$142B
$80K 0.02%
296
-1
-0.3% -$272
BIO icon
180
Bio-Rad Laboratories Class A
BIO
$8.08B
$79K 0.02%
106
-65
-38% -$48.7K
THD icon
181
iShares MSCI Thailand ETF
THD
$361M
$79K 0.02%
1,054
-353
-25% -$26.6K
HD icon
182
Home Depot
HD
$332B
$77K 0.02%
235
+2
+0.9% +$657
LOW icon
183
Lowe's Companies
LOW
$115B
$76K 0.02%
377
+1
+0.3% +$199
TMO icon
184
Thermo Fisher Scientific
TMO
$196B
$73K 0.02%
128
– –
EL icon
185
Estee Lauder
EL
$30.3B
$72K 0.02%
241
– –
TYL icon
186
Tyler Technologies
TYL
$13.1B
$71K 0.02%
155
-1
-0.6% -$478
MNST icon
187
Monster Beverage
MNST
$93.4B
$69K 0.02%
1,556
-4
-0.3% -$189
WIP icon
188
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$482M
$68K 0.02%
1,246
-440
-26% -$24.9K
DE icon
189
Deere & Co
DE
$158B
$67K 0.02%
201
– –
GLW icon
190
Corning
GLW
$132B
$60K 0.02%
1,649
+6
+0.4% +$240
ROL icon
191
Rollins
ROL
$21.5B
$55K 0.01%
1,544
– –
BMY icon
192
Bristol-Myers Squibb
BMY
$123B
$42K 0.01%
710
– –
VSXY
193
Victoria's Secret
VSXY
$6.95B
$41K 0.01%
+748
New +$45.4K
IEF icon
194
iShares 7-10 Year Treasury Bond ETF
IEF
$47.4B
$32K 0.01%
+280
New +$32.7K
ABBV icon
195
AbbVie
ABBV
$448B
– –
-425
Closed -$48K
ADCT icon
196
ADC Therapeutics
ADCT
$160M
– –
-26,000
Closed -$633K
APLS
197
DELISTED
Apellis Pharmaceuticals
APLS
– –
-2,000
Closed -$126K
AUPH icon
198
Aurinia Pharmaceuticals
AUPH
$1.96B
– –
-25,000
Closed -$324K
BFK
199
DELISTED
BlackRock Municipal Income Trust
BFK
– –
-1,900
Closed -$29K
BLE
200
DELISTED
BlackRock Municipal Income Trust II
BLE
– –
-9,065
Closed -$143K
5 6 7
8
9

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, AlphaCentric Advisors held 223 positions worth $393M, up 6.9% from $368M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

AlphaCentric Advisors deployed $32.9M of net new capital in Q3 2021, opening 14 new positions and adding to 85 existing holdings. Its largest new stake was Seres Therapeutics: 8,275 shares worth $1.15M.

By sector, the portfolio is most concentrated in Real Estate at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $1.02M trimmed.

  • AlphaCentric Advisors's largest Q3 2021 buy was Seres Therapeutics: 8,275 shares worth $1.15M.
  • AlphaCentric Advisors added most to iShares MBS ETF in Q3 2021, an estimated $10.8M increase.
  • AlphaCentric Advisors's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $1.02M.
  • AlphaCentric Advisors fully exited Ouster in Q3 2021, selling an estimated $1.06M.
  • AlphaCentric Advisors's ten largest holdings make up 81% of its $393M portfolio in Q3 2021.
  • AlphaCentric Advisors opened 14 new positions and closed 29 in Q3 2021.
  • AlphaCentric Advisors's portfolio value rose 6.9% quarter-over-quarter to $393M.

Based on AlphaCentric Advisors's 13F filing for Q3 2021, filed 9 Mar 2022.